|1.||Chatham, John C: 13 articles (01/2011 - 04/2004)|
|2.||Marchase, Richard B: 12 articles (02/2010 - 04/2004)|
|3.||Nagaoka, Isao: 10 articles (03/2013 - 04/2002)|
|4.||Reginster, Jean-Yves: 10 articles (10/2012 - 07/2003)|
|5.||Sakamoto, Koji: 9 articles (03/2013 - 04/2002)|
|6.||Bruyere, O: 8 articles (02/2008 - 12/2000)|
|7.||Pelletier, Jean-Pierre: 7 articles (01/2016 - 05/2006)|
|8.||Henrotin, Yves: 7 articles (01/2016 - 07/2003)|
|9.||Lampe, Johanna W: 7 articles (01/2015 - 09/2011)|
|10.||White, Emily: 7 articles (01/2015 - 05/2009)|
01/01/2011 - "Several clinical studies demonstrated that glucosamine sulfate (GS) is effective in controlling osteoarthritis (OA), showing a structure-modifying action. "
01/28/2008 - "This study explains the novel possibility of involvement of sulfated glucosamine in improving cellular antioxidant potential and thereby controlling oxidative damage that could be effective for its therapeutic potential in osteoarthritis. "
04/01/2007 - "Glucosamine sulfate (SGlc) has been known to be effective in controlling osteoarthritis (OA) symptoms in several clinical studies. "
01/01/2003 - "In short-term clinical trials, glucosamine provided effective symptomatic relief for patients with osteoarthritis of the knee. "
10/01/2001 - "Clinical studies indicate that glucosamine sulfate has been shown to be a safe and relatively effective treatment for osteoarthritis. "
01/01/2012 - "Hence, glucosamine was at first recommended by EULAR and OARSI for the management of knee pain and structure improvement in OA patients, but not in the most recent NICE guidelines. "
01/01/2013 - "Conflicting evidence was demonstrated with pain scores with two studies showing no difference and one study with a high risk-of-bias showing both a statistically and clinically significant improvement from taking glucosamine. "
01/01/2015 - "Compared to placebo, glucosamine showed a significant improvement with unstandardized mean differences (UMD) in total WOMAC, pain WOMAC, function WOMAC, and Lequesne score of -2.49 (95% confidence interval (CI) -4.14, -0.83), -0.75 (95% CI: -1.18, -0.32), -4.78 (95% CI: -5.96, -3.59), and -1.03 (95% CI: -1.34, -0.72), respectively. "
01/01/2013 - "Post treatment pain and mandibular opening showed significantly more improvement in the glucosamine treated patients (P < 0.0001 and 0.01 respectively). "
07/01/2007 - "Glucosamine significantly improved pain (mean change on VAS = -1.4, 95% CI -0.6 to -2.2; p = 0.002) and activity restriction (-1.9, 95% CI -1.0 to -2.8; p<0.001). "
01/01/2012 - "A randomized comparative study of safety and efficacy of immediate release glucosamine HCL and glucosamine HCL sustained release formulation in the treatment of knee osteoarthritis: A proof of concept study."
01/01/2012 - "To compare the safety and efficacy of glucosamine HCl- sustained release (GLU-SR) with that of Glucosamine HCl- immediate release (GLU-IR) in patients with knee osteoarthritis (OA). "
02/01/2013 - "Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles."
08/15/2005 - "Efficacy of glucosamine sulfate in knee osteoarthritis: comment on the article by Cibere et al."
10/15/2004 - "To assess the efficacy of glucosamine sulfate in knee osteoarthritis (OA). "
06/01/2015 - "The goal of our study was to investigate the effects of glucosamine on intervertebral disc cells in vitro under the physiological conditions of inflammation and mechanical loading. "
02/27/2010 - "In this study, we investigated the direct effects of glucosamine and related compounds on mast cell mediated inflammation using cultured mast cells and an animal model. "
09/01/2015 - "Glucosamine has been shown to act as an anti-inflammation molecule. "
07/01/2012 - "Suppression of Transglutaminase-2 is Involved in Anti-Inflammatory Actions of Glucosamine in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation."
06/10/2010 - "Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells."
|5.||Arthralgia (Joint Pain)
05/01/1998 - "Limited data from short-term human trials suggest that glucosamine sulfate administered orally, intravenously, intramuscularly, and intraarticularly may produce a gradual and progressive reduction in joint pain and tenderness, as well as improved range of motion and walking speed. "
01/29/2007 - "A 3 months', post-marketing, randomised, double-blinded, placebo-controlled, clinical trial was performed with parallel groups of 66 patients over 40 years of age with joint pain of long duration receiving either recommend dosage (1500 mg per day) of glucosamine sulphate or placebo. "
03/01/2002 - "The conclusion is that glucosamine is effective in relieving joint pain associated with osteoarthritis. "
04/01/2013 - "We conducted a single-arm, open-label, phase II study evaluating glucosamine-sulfate (1,500 mg/day) + chondroitin-sulfate (1,200 mg/day) for 24 weeks to treat joint pain/stiffness in postmenopausal women with early stage breast cancer who developed moderate-to-severe joint pain after initiating AIs. "
01/01/2009 - "Glucosamine is a herbal remedy commonly used to ease joint pain in osteoarthritis, and only two previous reports of hepatotoxicity have been published in the scientific literature. "
|2.||Chondroitin Sulfates (Chondroitin Sulfate)
|7.||Proteins (Proteins, Gene)
|8.||Hyaluronic Acid (Hyaluronan)
|9.||Collagen Type II (Type II Collagen)
|10.||Alendronate (Alendronate Sodium)
|4.||Heterologous Transplantation (Xenotransplantation)
|5.||Complementary Therapies (Alternative Medicine)